Related Experiment Video
Updated: Aug 2, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Human health risk assessment: a historical overview and alternative paths forward
1Chemistry Industry Institute of Toxicology, PO Box 12137, 6 Davis Drive, Research Triangle Park, NC 27709-2137, USA. mcclellan@ciit.org
Abstract:
Risk assessment has become a more structured activity during the past 50 years and increasingly is being used to inform major policy decisions. Much use has been made of the hazard identification phase of risk assessment to identify potentially hazardous materials or situations and guide actions to minimize potential risks. Much less frequently the process has been carried further, with estimates developed of the potency of the hazardous agent for causing adverse effects. And even less frequently, robust estimates of exposure have been developed. Thus, in only a few instances have risks been fully characterized in quantitative terms for either individuals or populations. To develop scientifically valid risk characterizations for many chemicals, much more scientific information must be acquired in a targeted manner to establish the potency of chemicals for causing cancer or other adverse health effects. Similar substantial effort must also be applied to characterizing the exposure populations receive from specific chemicals released from various source categories. In the absence of these scientifically rigorous approaches it is likely that societal actions will be guided primarily by identification of potential hazardous agents, with attempts made to minimize the hazard by banning or restricting use of the agent. This precautionary approach may not yield the maximum reduction in health risks to society for the investments made and, in addition, may deny society access to materials or processes that under appropriate conditions of use would not result in significant health risks and may indeed, have substantial net benefits to society.
Related Concept Videos
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Toxicity Testing in Animals
Criteria for Causality: Bradford Hill Criteria - II
Hazard Ratio
For example, in a clinical trial evaluating a...
Hazard Analysis and Critical Control Points (HACCP)

